Investing Ideas
/
Global Pharmaceuticals & Biotech High Return On Equity, Low Debt

Global Pharmaceuticals & Biotech High Return On Equity, Low Debt

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

22 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MRK Merck	US$89.50	7.8%	-30.9%	US$221.8b	US$114.05	PE13.2x	E7.6%	3.6%
WAT Waters	US$374.82	1.4%	13.2%	US$22.6b	US$398.96	PE34.9x	E8.8%	n/a
MEDP Medpace Holdings	US$340.22	0.01%	-15.3%	US$10.5b	US$344.83	PE25.6x	E9.6%	n/a
ORNBV Orion Oyj	€52.44	1.7%	36.2%	€7.3b	€53.60	PE22.2x	E12.8%	3.1%
500488 Abbott India	₹28,944.20	3.9%	0.9%	₹615.0b	₹29,838.57	PE46.1x	E11.2%	1.4%
688278 Xiamen Amoytop Biotech	CN¥86.17	4.8%	48.2%	CN¥35.1b	CN¥87.23	PE47.3x	E31.7%	0.5%
PTGX Protagonist Therapeutics	US$38.49	-0.5%	39.0%	US$2.3b	US$58.40	PE13.4x	E-7.2%	n/a
AGIO Agios Pharmaceuticals	US$35.22	6.0%	6.8%	US$1.9b	US$55.14	PE3x	E-13.6%	n/a
MDXG MiMedx Group	US$7.98	-5.0%	-2.7%	US$1.2b	US$13.40	PE14.8x	E-1.9%	n/a
500126 Procter & Gamble Health	₹5,290.50	1.3%	4.1%	₹87.8b	n/a	PE37.1x	E8.2%	3.0%
JSLL Jeena Sikho Lifecare	₹1,788.25	-0.3%	102.9%	₹44.5b	n/a	PE52.8x	n/a	0.2%
HVO hVIVO	UK£0.18	-1.4%	-34.7%	UK£120.8m	UK£0.32	PE6.9x	E-31.0%	1.1%
GRIN Grown Rogue International	CA$0.89	1.1%	32.8%	CA$193.4m	n/a	PE36.1x	n/a	n/a
93M1 MPH Health Care	€23.60	4.4%	5.8%	€96.8m	€108.00	PE0.8x	E-65.7%	5.1%
INDSWFTLAB Ind-Swift Laboratories	₹93.58	1.8%	-16.6%	₹5.5b	n/a	PE1.6x	n/a	n/a
EZZ EZZ Life Science Holdings	AU$1.99	-1.7%	305.1%	AU$93.6m	AU$5.45	PE13.4x	E17.9%	1.5%
A067290 JW Shinyak	₩1,502.00	-0.2%	-25.4%	₩79.9b	n/a	PE10.9x	n/a	0%
6817 Winston Medical Supply	NT$94.10	0.7%	-11.6%	NT$1.7b	n/a	PE11.6x	n/a	7.0%
690 Uni-Bio Science Group	HK$0.056	7.7%	-34.9%	HK$334.4m	n/a	PE3.4x	n/a	n/a
CPCI Kahira Pharmaceuticals & Chemical Industries	ج.م128.13	18.9%	60.3%	ج.م1.9b	n/a	PE5.2x	n/a	10.0%
SCNI Scinai Immunotherapeutics	US$3.52	5.4%	-28.2%	US$2.9m	n/a	PE0.6x	n/a	n/a
CPTR Captor Capital	CA$0.89	0%	-30.2%	CA$3.1m	n/a	PE0.2x	n/a	n/a

Page 1 of 1